Advertisement
Advertisement

SGMT

SGMT logo

Sagimet Biosciences Inc. Series A Common Stock

8.52
USD
+0.39
+4.79%
Oct 31, 15:00 UTC -5
Closed
exchange

Pre-Market

8.40

-0.12
-1.35%

Sagimet Biosciences Inc. Series A Common Stock Profile

About

Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company. It involved in developing novel therapeutics targeting dysfunctional metabolic pathways. Sagimet Biosciences Inc. is based in SAN MATEO, Calif.

Info & Links

CEO

David Happel

Headquarters

155 BOVET RD., SUITE 303
SAN MATEO, CA 94402, UNITED STATES

Sector

Medical

Auditor

Deloitte & Touche LLP

Share holders

50

Employees

14

Sagimet Biosciences Inc. Series A Common Stock Statistics

Valuation Measures

Market Capitalization2

273.34M

Enterprise Value

231.02M

Enterprise Value/EBITDA(ttm)

-3.39

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.11

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-39.88%

Return on Invested Capital(ttm)

-40.02%

Return on Assets(ttm)

-38.40%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-68.23M

Net Income Available to Common(ttm)

-59.38M

Diluted EPS(ttm)

-1.83

Share Statistics

Beta (5Y Monthly)

3.26

52-Week Change

59.85%

S&P 500 52-Week Change

19.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

32.52M

Dividend Yield

0.00%

Float4

27.74M

% Held by Insiders

14.70%

% Held by Institutions

87.86%

Balance Sheet

Total Cash(mrq)

125.41M

Total Cash Per Share(mrq)

3.86

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

17.55%

Quick Ratio(mrq)

17.55%

Book Value Per Share(mrq)

4.04

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.73

Free Cash Flow(ytd)

-23.64M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement